• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number 72006
Device Problem Migration (4003)
Patient Problem Inadequate Pain Relief (2388)
Event Date 11/10/2023
Event Type  Injury  
Manufacturer Narrative
Patient event during the surgical procedure is not likely caused by the nalu system itself.Cessation of breathing function is a known inherent risk of anesthesia associated with surgical procedures.There are no reports of external trauma or other events that are likely to have caused or contributed to lead migration and subsequent fracture.Migration of components is a known risk of implantable neuromodulation systems and likely contributed to the subsequent fracture of the lead.
 
Event Description
Patient was implanted with the nalu peripheral nerve stimulator on (b)(6) 2023 to treat pelvic area pain.After programing the patient reported receiving approximately 75% pain relief in the targeted areas, however the patient reported new onset of hip pain after activation of the system.Physician performed a ganglion impar neurotomy to address the hip pain on 07jun2023 and fluoroscopy performed during the procedure showed that both of the nalu implanted leads had migrated superiorly from the initial implant location, possibly hitting a branch nerve and contributing to hip pain.A surgical revision was performed on (b)(6) 2023 and found that one of the implanted leads had also fractured.Both implanted leads were replaced during the procedure and new leads were placed in a more optimal location.During the procedure, after replacing both leads and prior to closure, the patient's breathing ceased and measures were required to restore breathing.After stabilizing the patient's vital signs, the new leads were connected to the existing implantable pulse generator (ipg) and intra-op testing was completed.Patient verbalized receiving paresthesia during testing, all impedance and depth checks were performed, and the procedure was completed with no further complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
NALU MEDICAL INC
2320 faraday avenue
suite 100
calsbad CA 92008
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad
Manufacturer Contact
terry villarba
2320 faraday avenue
suite 100
carlsbad, CA 92008-7241
7604482360
MDR Report Key18280199
MDR Text Key329889207
Report Number3015425075-2023-00301
Device Sequence Number1
Product Code GZF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183579
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number72006
Device Catalogue Number72006
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-